|
TMBIM4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.151500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.199800E-01 |
| Normal-vs-Stage2 |
1.016580E-01 |
| Normal-vs-Stage3 |
1.276390E-02 |
| Normal-vs-Stage4 |
1.658100E-03 |
| Stage1-vs-Stage2 |
3.945400E-01 |
| Stage1-vs-Stage3 |
5.805700E-02 |
| Stage1-vs-Stage4 |
8.302300E-03 |
| Stage2-vs-Stage3 |
6.771200E-01 |
| Stage2-vs-Stage4 |
2.428000E-01 |
| Stage3-vs-Stage4 |
3.176400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.400500E-02 |
| Normal-vs-AfricanAmerican |
5.687400E-01 |
| Normal-vs-Asian |
1.396250E-01 |
| Caucasian-vs-AfricanAmerican |
5.135200E-01 |
| Caucasian-vs-Asian |
6.846400E-01 |
| AfricanAmerican-vs-Asian |
7.295800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.409700E-02 |
| Normal-vs-Female |
6.608000E-02 |
| Male-vs-Female |
5.091400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.687000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.768000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.541830E-02 |
| Normal-vs-Age(81-100Yrs) |
4.631600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.858200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.234200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.485200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.323600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.161200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.284000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.333600E-02 |
| Classical-VS-Follicular |
5.419000E-01 |
| Classical-VS-Other |
3.876200E-01 |
| Classical-VS-Normal |
1.231370E-01 |
| Tall-VS-Follicular |
3.219800E-02 |
| Tall-VS-Other |
8.458600E-01 |
| Tall-VS-Normal |
3.476200E-03 |
| Follicular-VS-Other |
1.103420E-01 |
| Follicular-VS-Normal |
4.812800E-01 |
| Other-VS-Normal |
1.021400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.070990E-01 |
| Normal-vs-N1 |
1.186130E-02 |
| N0-vs-N1 |
2.002600E-01 |
|
|
